Mardon McFarlane

Mardon McFarlane is a co-founder of a consultancy, Taxo Bioscience, that specialises in supporting pre-clinical and clinical stage biotech companies, by ensuring they make the correct, impactful decisions early in their journey to bring life-changing therapies to patients.  Mardon specialises in the CMC aspect of drug discovery and has been involved in notable drug approvals during his 17+ years in the industry. His experience in the biotechnology sector started with biologics but over the last 10+ years he has migrated to the cutting-edge sector of cell and gene therapy. Mardon’s career has been focused on the processing aspects of drug manufacture and has spanned process development, technology transfer, scale up and large-scale manufacturing. Mardon holds an MEng in Biochemical Engineering from University College London.

Training format

Topic

  • Next: 2-6 Dec 2024 Live online

Biotechnology for the Non-Biotechnologist

Live online

An ideal course for non-scientists and scientists who need to understand the basic theory, principles, techniques and potential of biotechnology.

  • 18 CPD hours Focused
  • Presented by Mardon McFarlane